2022-07-04
Ohashi H Hishiki T Akazawa D Kim KS Woo J Shionoya K Tsuchimoto K Iwanami S Moriyama S Kinoshita H Yamada S Kuroda Y Yamamoto T Kishida N Watanabe S Hasegawa H Ebihara H Suzuki T Maeda K Fukushi S Takahashi Y Iwami S Watashi K
2022-04
Kumata R Iwanami S Mar KB Kakizoe Y Misawa N Nakaoka S Koyanagi Y Perelson AS Schoggins JW Iwami S Sato K
2022-03-26
Yoshida M Kobashi Y Kawamura T Shimazu Y Nishikawa Y Omata F Zhao T Yamamoto C Kaneko Y Nakayama A Takita M Ito N Kawashima M Sugiura S Shibuya K Iwami S Kim K Iwanami S Kodama T Tsubokura M
2021-10
Kim KS Iwanami S Oda T Fujita Y Kuba K Miyazaki T Ejima K Iwami S
2021-07-27
Jeong YD Ejima K Kim KS Iwanami S Bento AI Fujita Y Jung IH Aihara K Watashi K Miyazaki T Wakita T Iwami S Ajelli M
2021-07
Iwanami S Ejima K Kim KS Noshita K Fujita Y Miyazaki T Kohno S Miyazaki Y Morimoto S Nakaoka S Koizumi Y Asai Y Aihara K Watashi K Thompson RN Shibuya K Fujiu K Perelson AS Iwami S Wakita T
2021-06
Ejima K Kim KS Ludema C Bento AI Iwanami S Fujita Y Ohashi H Koizumi Y Watashi K Aihara K Nishiura H Iwami S
2021-04-30
Shionoya K Yamasaki M Iwanami S Ito Y Fukushi S Ohashi H Saso W Tanaka T Aoki S Kuramochi K Iwami S Takahashi Y Suzuki T Muramatsu M Takeda M Wakita T Watashi K
2021-04-23
Ohashi H Watashi K Saso W Shionoya K Iwanami S Hirokawa T Shirai T Kanaya S Ito Y Kim KS Nomura T Suzuki T Nishioka K Ando S Ejima K Koizumi Y Tanaka T Aoki S Kuramochi K Suzuki T Hashiguchi T Maenaka K Matano T Muramatsu M Saijo M Aihara K Iwami S Takeda M McKeating JA Wakita T
2021-04
Ejima K Kim KS Iwanami S Fujita Y Li M Zoh RS Aihara K Miyazaki T Wakita T Iwami S
2021-03
Kim KS Ejima K Iwanami S Fujita Y Ohashi H Koizumi Y Asai Y Nakaoka S Watashi K Aihara K Thompson RN Ke R Perelson AS Iwami S
2021
Akao M Woo J Iwami S Iwanami S
2020-07
Iwanami S Kitagawa K Ohashi H Asai Y Shionoya K Saso W Nishioka K Inaba H Nakaoka S Wakita T Diekmann O Iwami S Watashi K
2020-06
Ono C Fukuhara T Li S Wang J Sato A Izumi T Fauzyah Y Yamamoto T Morioka Y Dokholyan NV Standley DM Matsuura Y
2019-10-21
Hara A Iwanami S Ito Y Miura T Nakaoka S Iwami S
2017-04-21
Iwanami S Kakizoe Y Morita S Miura T Nakaoka S Iwami S
アイウエオ
書類用論文リスト
論文
Haruna Yamakoshi, Mihoko Horigome, Shotaro Yamamoto, Shoya Iwanami, Shingo Iwami, Ryoya Tanaka, Yuki Ishikawa, Azusa Kamikouchi*.
Mating status-dependent dopaminergic modulation of auditory sensory neurons in Drosophila.
iScience (2025) Volume 28, Issue 9, 113232.
DOI: 10.1016/j.isci.2025.113232
Shoya Iwanami*, Toshiko Sato, Hiroshi Haeno, Longchen Xu, Keimyo Imamura, Jun Ooehara, Xun Lan, Hiromitsu Nakauchi, Shingo Iwami, Ryo Yamamoto*.
Stable platelet production via the bypass pathway explains long-term hematopoietic stem cell reconstitution.
iScience (2025) Volume 28, Issue 6, 112547.
DOI: 10.1016/j.isci.2025.112547
Yong Dam Jeong†, Keisuke Ejima†*, Kwang Su Kim†, Shoya Iwanami, William S. Hart, Robin N. Thompson, Il Hyo Jung, Shingo Iwami*, Marco Ajelli‡, Kazuyuki Aihara‡.
A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks.
Communications Medicine (2025) 5, 2.
DOI: 10.1038/s43856-024-00716-3
Naotoshi Nakamura†, Yurie Kobashi†, Kwang Su Kim†, Hyeongki Park†, Yuta Tani, Yuzo Shimazu, Tianchen Zhao, Yoshitaka Nishikawa, Fumiya Omata, Moe Kawashima, Makoto Yoshida, Toshiki Abe, Yoshika Saito, Yuki Senoo, Saori Nonaka, Morihito Takita, Chika Yamamoto, Takeshi Kawamura, Akira Sugiyama, Aya Nakayama, Yudai Kaneko, Yong Dam Jeong, Daiki Tatematsu, Marwa Akao, Yoshitaka Sato, Shoya Iwanami, Yasuhisa Fujita, Masatoshi Wakui, Kazuyuki Aihara, Tatsuhiko Kodama, Kenji Shibuya, Shingo Iwami‡*, Masaharu Tsubokura‡*.
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
PLOS Digital Health (2024) 3(5): e0000497.
DOI: 10.1371/journal.pdig.0000497
Hyeongki Park, Raiki Yoshimura, Shoya Iwanami, Kwang Su Kim, Keisuke Ejima, Naotoshi Nakamura, Kazuyuki Aihara, Yoshitsugu Miyazaki, Takashi Umeyama, Ken Miyazawa, Takeshi Morita, Koichi Watashi, Christopher B. Brooke, Ruian Ke, Shingo Iwami†*, Taiga Miyazaki†*.
Stratification of viral shedding patterns in saliva of COVID-19 patients.
eLife (2024) 13:RP96032.
DOI: 10.7554/eLife.96032.1
Teiko Kawahigashi†, Shoya Iwanami†, Munetomo Takahashi, Joydeep Bhadury, Shingo Iwami*, Satoshi Yamazaki*.
Age-related changes in the hematopoietic stem cell pool revealed via quantifying the balance of symmetric and asymmetric divisions.
PLOS ONE (2024) 19(1): e0292575.
DOI: 10.1371/journal.pone.0292575
Taiga Miyazaki*, Naoki Hosogaya, Yuri Fukushige, Sachiko Takemori, Shinpei Morimoto, Hiroshi Yamamoto, Makoto Hori, Yoshihito Ozawa, Yuki Shiko, Yosuke Inaba, Tomoya Kurokawa, Hideki Hanaoka, Shoya Iwanami, Kwangsu Kim, Shingo Iwami, Koichi Watashi, Ken Miyazawa, Takashi Umeyama, Satoshi Yamagoe, Yoshitsugu Miyazaki, Takaji Wakita, Makoto Sumiyoshi, Tatsuro Hirayama, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae, Hitoshi Kawasuji, Yoshihiro Yamamoto, Norihito Tarumoto, Hiroshi Ishii, Hideaki Ohno, Kazuhiro Yatera, Hiroshi Kakeya, Yoshiko Kichikawa, Yasuyuki Kato, Tetsuya Matsumoto, Makoto Saito, Hiroshi Yotsuyanagi, Shigeru Kohno.
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.
Microbiology Spectrum (2023) e04311-22.
DOI: 10.1128/spectrum.04311-22
Shiho Torii†, Kwang Su Kim†, Jun Koseki†, Rigel Suzuki†, Shoya Iwanami, Yasuhisa Fujita, Yong Dam Jeong, Jumpei Ito, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato, Yoshiharu Matsuura*, Teppei Shimamura*, Shingo Iwami*, Takasuke Fukuhara*.
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir.
PLOS Pathogens (2023) 19(3): e1011231.
DOI: 10.1371/journal.ppat.1011231
Daisuke Akazawa†, Hirofumi Ohashi†, Takayuki Hishiki‡, Takeshi Morita‡, Shoya Iwanami§, Kwang Su Kim§, Yong Dam Jeong§, Eun-Sil Park, Michiyo Kataoka, Kaho Shionoya, Junki Mifune, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Hyeongki Park, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Shingo Iwami, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi*.
Potential anti-mpox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments.
The Journal of Infectious Diseases (2023) jiad058.
DOI: 10.1093/infdis/jiad058
Daiki Tatematsu†, Marwa Akao†, Hyeongki Park†, Shingo Iwami, Keisuke Ejima, Shoya Iwanami*.
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors.
Journal of Theoretical Biology (2023) 561:111403.
DOI: 10.1016/j.jtbi.2022.111403
Yong Dam Jeong†, Keisuke Ejima†*, Kwang Su Kim†, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, Il Hyo Jung, Kazuyuki Aihara, Kenji Shibuya, Shingo Iwami*, Ana I. Bento, Marco Ajelli.
Designing isolation guidelines for COVID-19 patients with rapid antigen tests.
Nature Communications (2022) 13, 4910.
DOI: 10.1038/s41467-022-32663-9
Keisuke Ejima†*, Kwang Su Kim†, Ana I. Bento†, Shoya Iwanami, Yasuhisa Fujita, Kazuyuki Aihara, Kenji Shibuya, Shingo Iwami*.
Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study.
BMC Infectious Diseases (2022) 22, 656.
DOI: 10.1186/s12879-022-07646-2
Hirofumi Ohashi†, Takayuki Hishiki†, Daisuke Akazawa†, Kwang Su Kim†, Joohyeon Woo†, Kaho Shionoya, Kana Tsuchimoto, Shoya Iwanami, Saya Moriyama, Hitomi Kinoshita, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Hideki Ebihara, Tadaki Suzuki, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Shingo Iwami*, Koichi Watashi*.
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
Antiviral Research (2022) 105372.
DOI: 10.1016/j.antiviral.2022.105372
Ryuichi Kumata†, Shoya Iwanami†, Katrina B. Mar, Yusuke Kakizoe, Naoko Misawa, Shinji Nakaoka, Yoshio Koyanagi, Alan S. Perelson, John W. Schoggins, Shingo Iwami*, Kei Sato*.
Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection.
PLOS Computational Biology (2022) 18(4): e1010053.
DOI: 10.1371/journal.pcbi.1010053
Makoto Yoshida, Yurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, Yoshitaka Nishikawa, Fumiya Omata, Tianchen Zhao, Chika Yamamoto, Yudai Kaneko, Aya Nakayama, Morihito Takita, Naomi Ito, Moe Kawashima, Sota Sugiura, Kenji Shibuya, Shingo Iwami, Kwangsu Kim, Shoya Iwanami, Tatsuhiko Kodama, Masaharu Tsubokura*.
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
Vaccines (2022) 10(4):515.
DOI: 10.3390/vaccines10040515
Marwa Akao†, Joohyeon Woo†, Shingo Iwami, Shoya Iwanami*.
Detection of significant antiviral drug effects on COVID-19 using viral load and PCR-positive rate in randomized controlled trials.
Translational and Regulatory Sciences (2021) Volume 3 Issue 3 Pages 85-88.
DOI: 10.33611/trs.2021-025
Kwang Su Kim†, Shoya Iwanami†, Takafumi Oda, Yasuhisa Fujita, Keiji Kuba, Taiga Miyazaki, Keisuke Ejima*, Shingo Iwami*.
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection.
Life Science Alliance (2021) 4 (10) e202101049.
DOI: 10.26508/lsa.202101049
Yong Dam Jeong†, Keisuke Ejima†*, Kwang Su Kim†, Shoya Iwanami, Ana I Bento, Yasuhisa Fujita, Il Hyo Jung, Kazuyuki Aihara, Koichi Watashi, Taiga Miyazaki, Takaji Wakita, Shingo Iwami*, Marco Ajelli.
Revisiting the guidelines for ending isolation for COVID-19 patients.
eLife (2021) 10:e69340.
DOI: 10.7554/eLife.69340
Shoya Iwanami†, Keisuke Ejima†*, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, Shigeru Kohno, Yoshitsugu Miyazaki, Shimpei Morimoto, Shinji Nakaoka, Yoshiki Koizumi, Yusuke Asai, Kazuyuki Aihara, Koichi Watashi, Robin N. Thompson, Kenji Shibuya, Katsuhito Fujiu, Alan S. Perelson‡, Shingo Iwami‡*, Takaji Wakita.
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
PLOS Medicine (2021) 18(7):e1003660.
DOI: 10.1371/journal.pmed.1003660
Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Shingo Iwami, Yoshimasa Takahashi, Tadaki Suzuki, Masamichi Muramatsu, Makoto Takeda, Takaji Wakita, Koichi Watashi*.
Mefloquine, a potent anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) drug as an entry inhibitor in vitro.
Frontiers in Microbiology (2021) 12:651403.
DOI: 10.3389/fmicb.2021.651403
Keisuke Ejima†*, Kwang Su Kim†, Shoya Iwanami†, Yasuhisa Fujita, Ming Li, Roger S. Zoh, Kazuyuki Aihara, Taiga Miyazaki, Takaji Wakita, Shingo Iwami*.
Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model.
Journal of the Royal Society Interface (2021) 18: 20200947. 20200947..
DOI: 10.1098/rsif.2020.0947
Keisuke Ejima†*, Kwang Su Kim†, Christina Ludema, Ana I. Bento, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Koichi Watashi, Kazuyuki Aihara, Hiroshi Nishiura, Shingo Iwami*.
Estimation of the incubation period of COVID-19 using viral load data.
Epidemics (2021) 100454.
DOI: 10.1016/j.epidem.2021.100454
Hirofumi Ohashi†, Koichi Watashi†*, Wakana Saso†, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim, Takao Nomura, Tateki Suzuki, Kazane Nishioka, Shuji Ando, Keisuke Ejima, Yoshiki Koizumi, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Tadaki Suzuki, Takao Hashiguchi, Katsumi Maenaka, Tetsuro Matano, Masamichi Muramatsu, Masayuki Saijo, Kazuyuki Aihara, Shingo Iwami, Makoto Takeda, Jane A. McKeating, Takaji Wakita.
Potential anti-COVID-19 agents, Cepharanthine and Nelfinavir, and their usage for combination treatment.
iScience (2021) 102367.
DOI: 10.1016/j.isci.2021.102367
Kwang Su Kim†, Keisuke Ejima†, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Kazuyuki Aihara, Robin N. Thompson, Ruian Ke, Alan S. Perelson‡*, Shingo Iwami‡*.
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
PLOS Biology (2021) 19(3): e3001128.
DOI: 10.1371/journal.pbio.3001128
Shoya Iwanami†, Kosaku Kitagawa†, Hirofumi Ohashi, Yusuke Asai, Kaho Shionoya, Wakana Saso, Kazane Nishioka, Hisashi Inaba, Shinji Nakaoka, Takaji Wakita, Odo Diekmann, Shingo Iwami‡*, Koichi Watashi‡*.
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma.
PLOS Biology (2020) 18(7): e3000562.
DOI: 10.1371/journal.pbio.3000562
Akane Hara†, Shoya Iwanami†, Yusuke Ito†, Tomoyuki Miura*, Shinji Nakaoka, Shingo Iwami*.
Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.
Journal of Theoretical Biology (2019) 479:29-36.
DOI: 10.1016/j.jtbi.2019.07.005
Shoya Iwanami, Yusuke Kakizoe, Satoru Morita, Tomoyuki Miura, Shinji Nakaoka, Shingo Iwami*.
A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture.
Theoretical Biology and Medical Modeling (2017) 14:9.
DOI: 10.1186/s12976-017-0055-8
論文
Haruna Yamakoshi, Mihoko Horigome, Shotaro Yamamoto, Shoya Iwanami, Shingo Iwami, Ryoya Tanaka, Yuki Ishikawa, Azusa Kamikouchi*.
Mating status-dependent dopaminergic modulation of auditory sensory neurons in Drosophila.
iScience. Volume 28, Issue 9, 113232.
(2025)
Shoya Iwanami*, Toshiko Sato, Hiroshi Haeno, Longchen Xu, Keimyo Imamura, Jun Ooehara, Xun Lan, Hiromitsu Nakauchi, Shingo Iwami, Ryo Yamamoto*.
Stable platelet production via the bypass pathway explains long-term hematopoietic stem cell reconstitution.
iScience. Volume 28, Issue 6, 112547.
(2025)
Yong Dam Jeong†, Keisuke Ejima†*, Kwang Su Kim†, Shoya Iwanami, William S. Hart, Robin N. Thompson, Il Hyo Jung, Shingo Iwami*, Marco Ajelli‡, Kazuyuki Aihara‡.
A modeling study to define guidelines for antigen screening in schools and workplaces to mitigate COVID-19 outbreaks.
Communications Medicine. 5, 2.
(2025)
Naotoshi Nakamura†, Yurie Kobashi†, Kwang Su Kim†, Hyeongki Park†, Yuta Tani, Yuzo Shimazu, Tianchen Zhao, Yoshitaka Nishikawa, Fumiya Omata, Moe Kawashima, Makoto Yoshida, Toshiki Abe, Yoshika Saito, Yuki Senoo, Saori Nonaka, Morihito Takita, Chika Yamamoto, Takeshi Kawamura, Akira Sugiyama, Aya Nakayama, Yudai Kaneko, Yong Dam Jeong, Daiki Tatematsu, Marwa Akao, Yoshitaka Sato, Shoya Iwanami, Yasuhisa Fujita, Masatoshi Wakui, Kazuyuki Aihara, Tatsuhiko Kodama, Kenji Shibuya, Shingo Iwami‡*, Masaharu Tsubokura‡*.
Modeling and predicting individual variation in COVID-19 vaccine-elicited antibody response in the general population.
PLOS Digital Health. 3(5): e0000497.
(2024)
Hyeongki Park, Raiki Yoshimura, Shoya Iwanami, Kwang Su Kim, Keisuke Ejima, Naotoshi Nakamura, Kazuyuki Aihara, Yoshitsugu Miyazaki, Takashi Umeyama, Ken Miyazawa, Takeshi Morita, Koichi Watashi, Christopher B. Brooke, Ruian Ke, Shingo Iwami†*, Taiga Miyazaki†*.
Stratification of viral shedding patterns in saliva of COVID-19 patients.
eLife. 13:RP96032.
(2024)
Teiko Kawahigashi†, Shoya Iwanami†, Munetomo Takahashi, Joydeep Bhadury, Shingo Iwami*, Satoshi Yamazaki*.
Age-related changes in the hematopoietic stem cell pool revealed via quantifying the balance of symmetric and asymmetric divisions.
PLOS ONE. 19(1): e0292575.
(2024)
Taiga Miyazaki*, Naoki Hosogaya, Yuri Fukushige, Sachiko Takemori, Shinpei Morimoto, Hiroshi Yamamoto, Makoto Hori, Yoshihito Ozawa, Yuki Shiko, Yosuke Inaba, Tomoya Kurokawa, Hideki Hanaoka, Shoya Iwanami, Kwangsu Kim, Shingo Iwami, Koichi Watashi, Ken Miyazawa, Takashi Umeyama, Satoshi Yamagoe, Yoshitsugu Miyazaki, Takaji Wakita, Makoto Sumiyoshi, Tatsuro Hirayama, Koichi Izumikawa, Katsunori Yanagihara, Hiroshi Mukae, Hitoshi Kawasuji, Yoshihiro Yamamoto, Norihito Tarumoto, Hiroshi Ishii, Hideaki Ohno, Kazuhiro Yatera, Hiroshi Kakeya, Yoshiko Kichikawa, Yasuyuki Kato, Tetsuya Matsumoto, Makoto Saito, Hiroshi Yotsuyanagi, Shigeru Kohno.
A Multicenter Randomized Controlled Trial To Evaluate the Efficacy and Safety of Nelfinavir in Patients with Mild COVID-19.
Microbiology Spectrum. e04311-22.
(2023)
Shiho Torii†, Kwang Su Kim†, Jun Koseki†, Rigel Suzuki†, Shoya Iwanami, Yasuhisa Fujita, Yong Dam Jeong, Jumpei Ito, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Kei Sato, Yoshiharu Matsuura*, Teppei Shimamura*, Shingo Iwami*, Takasuke Fukuhara*.
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir.
PLOS Pathogens. 19(3): e1011231.
(2023)
Daisuke Akazawa†, Hirofumi Ohashi†, Takayuki Hishiki‡, Takeshi Morita‡, Shoya Iwanami§, Kwang Su Kim§, Yong Dam Jeong§, Eun-Sil Park, Michiyo Kataoka, Kaho Shionoya, Junki Mifune, Kana Tsuchimoto, Shinjiro Ojima, Aa Haeruman Azam, Shogo Nakajima, Hyeongki Park, Tomoki Yoshikawa, Masayuki Shimojima, Kotaro Kiga, Shingo Iwami, Ken Maeda, Tadaki Suzuki, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi*.
Potential anti-mpox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments.
The Journal of Infectious Diseases. jiad058.
(2023)
Daiki Tatematsu†, Marwa Akao†, Hyeongki Park†, Shingo Iwami, Keisuke Ejima, Shoya Iwanami*.
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors.
Journal of Theoretical Biology. 561:111403.
(2023)
Yong Dam Jeong†, Keisuke Ejima†*, Kwang Su Kim†, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, Il Hyo Jung, Kazuyuki Aihara, Kenji Shibuya, Shingo Iwami*, Ana I. Bento, Marco Ajelli.
Designing isolation guidelines for COVID-19 patients with rapid antigen tests.
Nature Communications. 13, 4910.
(2022)
Keisuke Ejima†*, Kwang Su Kim†, Ana I. Bento†, Shoya Iwanami, Yasuhisa Fujita, Kazuyuki Aihara, Kenji Shibuya, Shingo Iwami*.
Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study.
BMC Infectious Diseases. 22, 656.
(2022)
Hirofumi Ohashi†, Takayuki Hishiki†, Daisuke Akazawa†, Kwang Su Kim†, Joohyeon Woo†, Kaho Shionoya, Kana Tsuchimoto, Shoya Iwanami, Saya Moriyama, Hitomi Kinoshita, Souichi Yamada, Yudai Kuroda, Tsukasa Yamamoto, Noriko Kishida, Shinji Watanabe, Hideki Hasegawa, Hideki Ebihara, Tadaki Suzuki, Ken Maeda, Shuetsu Fukushi, Yoshimasa Takahashi, Shingo Iwami*, Koichi Watashi*.
Different efficacies of neutralizing antibodies and antiviral drugs on SARS-CoV-2 Omicron subvariants, BA.1 and BA.2.
Antiviral Research. 105372.
(2022)
Ryuichi Kumata†, Shoya Iwanami†, Katrina B. Mar, Yusuke Kakizoe, Naoko Misawa, Shinji Nakaoka, Yoshio Koyanagi, Alan S. Perelson, John W. Schoggins, Shingo Iwami*, Kei Sato*.
Antithetic effect of interferon-α on cell-free and cell-to-cell HIV-1 infection.
PLOS Computational Biology. 18(4): e1010053.
(2022)
Makoto Yoshida, Yurie Kobashi, Takeshi Kawamura, Yuzo Shimazu, Yoshitaka Nishikawa, Fumiya Omata, Tianchen Zhao, Chika Yamamoto, Yudai Kaneko, Aya Nakayama, Morihito Takita, Naomi Ito, Moe Kawashima, Sota Sugiura, Kenji Shibuya, Shingo Iwami, Kwangsu Kim, Shoya Iwanami, Tatsuhiko Kodama, Masaharu Tsubokura*.
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community Survey.
Vaccines. 10(4):515.
(2022)
Marwa Akao†, Joohyeon Woo†, Shingo Iwami, Shoya Iwanami*.
Detection of significant antiviral drug effects on COVID-19 using viral load and PCR-positive rate in randomized controlled trials.
Translational and Regulatory Sciences. Volume 3 Issue 3 Pages 85-88.
(2021)
Kwang Su Kim†, Shoya Iwanami†, Takafumi Oda, Yasuhisa Fujita, Keiji Kuba, Taiga Miyazaki, Keisuke Ejima*, Shingo Iwami*.
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection.
Life Science Alliance. 4 (10) e202101049.
(2021)
Yong Dam Jeong†, Keisuke Ejima†*, Kwang Su Kim†, Shoya Iwanami, Ana I Bento, Yasuhisa Fujita, Il Hyo Jung, Kazuyuki Aihara, Koichi Watashi, Taiga Miyazaki, Takaji Wakita, Shingo Iwami*, Marco Ajelli.
Revisiting the guidelines for ending isolation for COVID-19 patients.
eLife. 10:e69340.
(2021)
Shoya Iwanami†, Keisuke Ejima†*, Kwang Su Kim, Koji Noshita, Yasuhisa Fujita, Taiga Miyazaki, Shigeru Kohno, Yoshitsugu Miyazaki, Shimpei Morimoto, Shinji Nakaoka, Yoshiki Koizumi, Yusuke Asai, Kazuyuki Aihara, Koichi Watashi, Robin N. Thompson, Kenji Shibuya, Katsuhito Fujiu, Alan S. Perelson‡, Shingo Iwami‡*, Takaji Wakita.
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
PLOS Medicine. 18(7):e1003660.
(2021)
Kaho Shionoya, Masako Yamasaki, Shoya Iwanami, Yusuke Ito, Shuetsu Fukushi, Hirofumi Ohashi, Wakana Saso, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Shingo Iwami, Yoshimasa Takahashi, Tadaki Suzuki, Masamichi Muramatsu, Makoto Takeda, Takaji Wakita, Koichi Watashi*.
Mefloquine, a potent anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) drug as an entry inhibitor in vitro.
Frontiers in Microbiology. 12:651403.
(2021)
Keisuke Ejima†*, Kwang Su Kim†, Shoya Iwanami†, Yasuhisa Fujita, Ming Li, Roger S. Zoh, Kazuyuki Aihara, Taiga Miyazaki, Takaji Wakita, Shingo Iwami*.
Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model.
Journal of the Royal Society Interface. 18: 20200947. 20200947..
(2021)
Keisuke Ejima†*, Kwang Su Kim†, Christina Ludema, Ana I. Bento, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Koichi Watashi, Kazuyuki Aihara, Hiroshi Nishiura, Shingo Iwami*.
Estimation of the incubation period of COVID-19 using viral load data.
Epidemics. 100454.
(2021)
Hirofumi Ohashi†, Koichi Watashi†*, Wakana Saso†, Kaho Shionoya, Shoya Iwanami, Takatsugu Hirokawa, Tsuyoshi Shirai, Shigehiko Kanaya, Yusuke Ito, Kwang Su Kim, Takao Nomura, Tateki Suzuki, Kazane Nishioka, Shuji Ando, Keisuke Ejima, Yoshiki Koizumi, Tomohiro Tanaka, Shin Aoki, Kouji Kuramochi, Tadaki Suzuki, Takao Hashiguchi, Katsumi Maenaka, Tetsuro Matano, Masamichi Muramatsu, Masayuki Saijo, Kazuyuki Aihara, Shingo Iwami, Makoto Takeda, Jane A. McKeating, Takaji Wakita.
Potential anti-COVID-19 agents, Cepharanthine and Nelfinavir, and their usage for combination treatment.
iScience. 102367.
(2021)
Kwang Su Kim†, Keisuke Ejima†, Shoya Iwanami, Yasuhisa Fujita, Hirofumi Ohashi, Yoshiki Koizumi, Yusuke Asai, Shinji Nakaoka, Koichi Watashi, Kazuyuki Aihara, Robin N. Thompson, Ruian Ke, Alan S. Perelson‡*, Shingo Iwami‡*.
A quantitative model used to compare within-host SARS-CoV-2, MERS-CoV, and SARS-CoV dynamics provides insights into the pathogenesis and treatment of SARS-CoV-2.
PLOS Biology. 19(3): e3001128.
(2021)
Shoya Iwanami†, Kosaku Kitagawa†, Hirofumi Ohashi, Yusuke Asai, Kaho Shionoya, Wakana Saso, Kazane Nishioka, Hisashi Inaba, Shinji Nakaoka, Takaji Wakita, Odo Diekmann, Shingo Iwami‡*, Koichi Watashi‡*.
Should a viral genome stay in the host cell or leave? A quantitative dynamics study of how hepatitis C virus deals with this dilemma.
PLOS Biology. 18(7): e3000562.
(2020)
Akane Hara†, Shoya Iwanami†, Yusuke Ito†, Tomoyuki Miura*, Shinji Nakaoka, Shingo Iwami*.
Revealing uninfected and infected target cell dynamics from peripheral blood data in highly and less pathogenic simian/human immunodeficiency virus infected Rhesus macaque.
Journal of Theoretical Biology. 479:29-36.
(2019)
Shoya Iwanami, Yusuke Kakizoe, Satoru Morita, Tomoyuki Miura, Shinji Nakaoka, Shingo Iwami*.
A highly pathogenic simian/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture.
Theoretical Biology and Medical Modeling. 14:9.
(2017)
プレプリント
Yasuhisa Fujita, Marwa Akao, Daiki Tatematsu, Shingo Iwami, Naotoshi Nakamura, Shoya Iwanami. Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection. bioRxiv. (2025) DOI: https://doi.org/10.1101/2025.05.02.651873
講演
Shoya Iwanami.
Use of viral clearance as a surrogate marker of epidemiological efficacy for anti-SARS-CoV-2 therapies.
7th Workshop on Virus Dynamics.
University of Bordeaux, Talence, France.
October 14, 2025.
Shoya Iwanami.
Quantifying heterogeneous in vivo population dynamics via mathematical modeling.
ACMB-JSMB2025, Joint Conference of Asian Conference on Mathematical Biology and Annual Meeting of Japanese Society for Mathematical Biology.
Kyoto Terrsa, Kyoto, Japan.
July 7, 2025.
Shoya Iwanami.
Mathematical modeling of hematopoiesis by age-specific and lineage-restricted hematopoietic stem cells.
ACMB-JSMB2025, Joint Conference of Asian Conference on Mathematical Biology and Annual Meeting of japanese Society for Mathematical Biology.
Kyoto Terrsa, Kyoto, Japan.
July 7, 2025.
Shoya Iwanami.
Mathematical Modeling of a Bypass Pathway to Myeloid Lineage in Hematopoietic Stem Cell Differentiation.
International Conference on Mathematical Biology.
Hotel Barahi, Pokhara, Nepal.
June 13, 2025.
Shoya Iwanami.
Modelling of immunology.
Collaborative initiative research workshop “Data Empowerment for Infectious Diseases clinical research: Perspectives from Japan and Singapore”.
Lee Kong Chian School of Medicine, Nanyang Technological University, Novena, Singapore.
October 7, 2024.
Shoya Iwanami.
Quantitative evaluation of bypass pathways on the differentiation potential of hematopoietic stem cells.
13th European Conference on Mathematical and Theoretical Biology.
Old weapons factory of Toledo, University of Castilla-La Mancha, Toledo Campus, Toledo, Spain.
July 22, 2024.
Shoya Iwanami.
Application of virus dynamics to the evaluation of antiviral drugs.
KSMB-SMB 2024 SEOUL.
Konkuk University, Seoul, Republic of Korea.
July 4, 2024.
Daiki Tatematsu, Marwa Akao, Hyeongki Park, Shingo Iwami, Keisuke Ejima, Shoya Iwanami.
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors.
Epidemics: 9th International Conference on Infectious Disease Dynamics.
Bologna Congress Centre, Bologna, Italy.
November 29, 2023.
Shoya Iwanami.
Quantification of age-related changes in hematopoietic stem cell differentiation.
6th Workshop on Virus Dynamics.
Noyori Confference Hall, Nagoya Universtiy, Nagoya, Japan.
July 4, 2023.
Shoya Iwanami.
Quantitative analysis of hematopoietic stem cell aging using population dynamics.
Interdisciplinary Science Conference in Okinawa (ISCO 2023).
OIST Auditorium, OIST, Okinawa, Japan.
February 27, 2023.
Shoya Iwanami.
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials.
5th Workshop on Virus Dynamics.
Virtual.
October 6, 2021.
Shoya Iwanami, Kosaku Kitagawa, Hirofumi Ohashi, Yusuke Asai, Koichi Watashi, Shingo Iwami.
A comparison between HCV JFH-1 and Jc1 strains by quantitative analysis of infection dynamics.
4th Workshop on Virus Dynamics.
University Paris Diderot, Paris, France.
October 21, 2019.
Shoya Iwanami, Kosaku Kitagawa, Hirofumi Ohashi, Yusuke Asai, Koichi Watashi, Shingo Iwami.
A quantitative comparison between hepatitis C virus JFH-1 and Jc1 by a PDE multiscale model of virus infection.
9th International Congress on Industrial and Applied Mathematics (ICIAM 2019).
Blasco Ibáñez Campus of the Universitat de València, Valencia, Spain.
July 16, 2019.
Shoya Iwanami, Ryo Yamamoto, Shingo Iwami and Hiroshi Haeno.
Data analysis of single-cell transplantation.
11th European Conference on Mathematical & Theoretical Biology and SMB Annual Meeting.
The University of Lisbon, Lisbon, Portugal.
July 24, 2018.
Shoya Iwanami, Ryo Yamamoto, Shingo Iwami and Hiroshi Haeno.
Data analysis of single-HSC transplantation.
2018 Annual Meeting of the Society for Mathematical Biology & the Japanese Society for Mathematical Biology.
The University of Sydney, Sydney, Australia.
July 9, 2018.
Shoya Iwanami, Ryo Yamamoto, Shingo Iwami and Hiroshi Haeno.
Data analysis of single-cell transplantation using mathematical model of Hematopoietic system with myeloid bypass.
Viral Immune Dynamics Workshop.
The University of New South Wales, Sydney, Australia.
December 4, 2017.
Shoya Iwanami, Ryo Yamamoto, Shingo Iwami and Hiroshi Haeno.
Mathematical model of hematopoietic system with myeloid bypass.
The 2017 Society for Mathematical Biology Annual meeting.
The University of Utah, UT, USA.
July 17, 2017.
Shoya Iwanami, Ryo Yamamoto, Shingo Iwami and Hiroshi Haeno.
Mathematical model of hematopoietic system with myeloid-restricted progenitors with long-term repopulating activity.
Systems Approaches in Immunology and Infectious Diseases.
Santa Fe, NM, USA.
September 27, 2016.
Shoya Iwanami, Ryo Yamamoto, Shingo Iwami and Hiroshi Haeno.
Mathematical model of hematopoietic system with myeloid-restricted progenitors with long-term repopulating activity.
10th European Conference on Mathematical & Theoretical Biology and SMB Annual Meeting.
Nottingham, UK.
July 12, 2016.
岩波 翔也.
造血幹細胞分化の数理モデリング.
第9回理論免疫学ワークショップ.
高知県立県民文化ホール, 高知.
2025年2月5日.
岩波 翔也.
数理モデルを用いた単一造血幹細胞クローン分化動態の解析.
定量生物学の会 九州キャラバン 2025.
九州大学馬出病院キャンパス, 福岡.
2025年1月11日.
岩波 翔也.
数理モデルを用いた単一造血幹細胞クローン分化動態の解析.
第47回日本分子生物学会年会.
福岡国際会議場 マリンメッセ福岡, 福岡.
2024年11月29日.
岩波 翔也.
造血幹細胞の分化におけるバイパス経路の定量的評価.
2024年度日本数理生物学会年会.
北海道大学学術交流会館, 札幌.
2024年9月13日.
岩波 翔也.
造血幹細胞の能力の定量的評価.
第８回理論免疫学ワークショップ.
いわて県民情報交流センター(アイーナ), 盛岡.
2024年2月14日.
岩波 翔也, 山本 将太朗, 日紫喜 隆行, 赤澤 大輔, 大橋 啓史, 森田 武志, 渡士 幸一, 岩見 真吾.
数理モデルを用いた抗サル痘ウイルス薬候補の定量的評価.
第70回日本ウイルス学会学術集会.
仙台国際センター, 仙台.
2023年9月27日.
岩波 翔也.
性質の異なる造血幹細胞の加齢に伴う変化の理解.
2023年度日本数理生物学会年会.
奈良女子大学, 奈良.
2023年9月5日.
岩波 翔也.
造血幹細胞の分化の数理モデルによるデータ解析.
第７回理論免疫学ワークショップ.
ライカ イチキューニーマル, 鹿児島 / Zoomウェビナー.
2023年3月20日.
岩波 翔也.
Mathematical modeling of immune cells.
第４回卓越大学院プログラム日英グローバルヘルスシンポジウム.
長崎大学, 長崎.
2023年1月23日.
岩波 翔也.
SARS-CoV-2の感染動態に基づくCOVID-19治療薬のランダム化比較試験の設計.
第69回日本ウイルス学会学術集会.
出島メッセ, 長崎.
2022年11月15日.
岩波 翔也.
数理モデルによる加齢に伴う造血幹細胞の分化様式の変化の理解.
2022年度日本数理生物学会年会.
オンライン.
2022年9月6日.
岩波 翔也.
数理モデルでとらえる細胞分化動態.
第６回理論免疫学ワークショップ.
オンライン.
2022年3月12日.
岩波 翔也.
数理科学で解明する造血幹細胞の分化.
新学術領域「細胞ダイバース」第4回若手ワークショップ.
オンライン.
2022年1月27日.
岩波 翔也.
細胞分化の数理モデルとデータ解析について.
第１回生命科学における数理解析探究ワークショップ.
北海道大学, 札幌.
2021年12月22日.
岩波 翔也.
SARS-CoV-2感染動態とCOVID-19 に対する数理モデル研究.
ウイルス学若手研究集会2021.
オンライン.
2021年12月11日.
岩波 翔也, 河東 堤子, 山崎 聡, 岩見 真吾.
数理科学で解明する造血幹細胞の分化.
第44回日本分子生物学会年会.
パシフィコ横浜, 横浜.
2021年12月1日.
岩波翔也, 江島啓介, Kim Kwangsu, 野下浩司, 岩見真吾.
SARS-CoV-2の感染動態に基づく抗ウイルス薬のランダム化比較試験での妥当なサンプルサイズの解析.
第68回日本ウイルス学会学術集会.
神戸国際会議場, 神戸, オンライン.
2021年11月16日.
岩波翔也, 北川耕咲, 大橋啓史, 浅井雄介, 塩野谷果歩, 佐宗若菜, 西岡華実, 稲葉寿, 中岡慎治, 脇田隆字, Odo Diekmann, 岩見真吾, 渡士幸一.
C型肝炎ウイルスの感染戦略：ウイルスゲノムは宿主細胞内にとどまるべきか？出ていくべきか？.
2020年度日本数理生物学会年会.
オンライン.
2020年9月20日.
岩波翔也.
造血幹細胞分化における骨髄球バイパスの機能.
第29回日本数理生物学会年会.
東京工業大学大岡山キャンパス, 東京.
2019年9月14日.
岩波翔也.
造血幹細胞分化の数理モデルと１細胞移植実験のデータ解析.
第3回学際的がん研究夏の学校@別府.
九州大学病院別府病院, 大分.
2019年7月27日.
岩波翔也.
マルチスケールモデルによるHCV感染動態の定量的解析.
第７６回京都駅前セミナー.
キャンパスプラザ京都, 京都.
2019年5月28日.
岩波翔也.
HCV JFH-1株とJc1株の感染動態の定量的解析.
第16回ウイルス学キャンプ.
ニューウェルシティ湯河原, 静岡.
2019年5月28日.
岩波翔也.
造血幹細胞移植実験のデータ解析.
新学術領域「細胞ダイバース」第2回若手ワークショップ.
仙台秋保 岩沼屋, 宮城.
2019年2月28日.
岩波翔也.
造血幹細胞分化の数理モデルと１細胞移植実験のデータ解析.
第3回理論免疫学ワークショップ.
秋田市にぎわい交流館, 秋田.
2019年1月24日.
Shoya Iwanami, Kosaku Kitagawa, Hirofumi Ohashi, Yusuke Asai, Koichi Watashi, Shingo Iwami.
A comparison between HCV JFH-1 and Jc1 strains by quantitative analysis of infection dynamics.
Innovative Mathematical Modeling for the Analysis of Infectious Disease Data (IMAID 2018).
Hanabishi Hotel, Hokkaido, Japan.
2019年1月17日.
岩波翔也.
造血幹細胞移植実験のデータ解析.
文部科学省科学研究費補助金新学術領域研究（研究領域提案型）「細胞社会ダイバーシティーの統合的解明と制御」（略称：細胞ダイバース）第3回公開シンポジウム「1細胞統合解析を駆使した組織内ダイバーシティー解明への挑戦」.
東京大学弥生キャンパス内弥生講堂・一条ホール, 東京.
2019年1月15日.
岩波翔也, 北川耕咲, 大橋啓史, 中岡慎治, 浅井雄介, 渡士幸一, 岩見真吾.
マルチスケールモデルによるHCV感染動態の定量的解析.
2018年度応用数学合同研究集会.
龍谷大学瀬田キャンパス, 滋賀.
2018年12月15日.
Shoya Iwanami，Hirofumi Ohashi，Yusuke Asai，Koichi Watashi，Shingo Iwami.
A comparison between HCV JFH-1 and Jc1 strains by quantitative analysis of infection dynamics.
第66回日本ウイルス学会学術集会.
京都テルサ, 京都.
2018年10月29日.
岩波翔也.
造血幹細胞移植実験のデータ解析.
第15回「生物数学の理論とその応用」-次世代の数理科学への展開-.
京都大学数理解析研究所, 京都.
2018年9月13日.
岩波翔也、北川耕咲、大橋啓史、中岡慎治、浅井雄介、岩見真吾、渡士幸一.
HCV JFH-1株およびJc1株のマルチスケール感染の定量的研究.
第15回ウイルス学キャンプ.
ニューウェルシティ湯河原, 静岡.
2018年6月6日.
岩波翔也、山本玲、岩見真吾、波江野洋.
１細胞移植実験のデータ解析.
第２回理論免疫学ワークショップ.
富山県民共生センターサンフォルテ, 富山.
2018年2月3日.
岩波翔也、北川耕咲、大橋啓史、中岡慎治、浅井雄介、渡士幸一、岩見真吾.
マルチスケールモデルを用いたHCV感染動態の定量的解析.
2017年度応用数学合同研究集会.
龍谷大学, 滋賀.
2017年12月15日.
岩波翔也、山本玲、岩見真吾、波江野洋.
Data analysis of single-cell transplantation using mathematical model of hematopoietic system with myeloid bypass.
特別計画 RIMS 共同研究（公開型） 第 14 回「生物数学の理論とその応用」―構造化個体群モデルとその応用―.
京都大学, 京都.
2017年11月8日.
Iwanami S. and Iwami S..
Characterizing SHIV infection in vitro.
Innovative Mathematical Modeling for the Analysis of Infectious Disease Data (IMAID2017).
Institute of Statistical Mathematics, Tokyo, Japan.
2017年10月23日.
岩波翔也、山本玲、岩見真吾、波江野洋.
Data analysis of single-cell transplantation using mathematical model of hematopoietic system with myeloid bypass.
第２７回日本数理生物学会年会.
北海道大学, 札幌.
2017年10月8日.
岩波翔也、中岡慎治、野下浩司、岩見真吾、篠原正浩.
Systems bone biology -骨の包括的理解から疾患制御へ-.
第3回日本骨免疫学会.
ANAコンチネンタルリゾートホテル, 沖縄.
2017年6月27日.
岩波翔也、北川耕咲、大橋啓史、中岡慎治、浅井雄介、岩見真吾、渡士幸一.
HCV JFH-1株とJ6/JFH-1株の感染動態の定量的解析.
第14回ウイルス学キャンプ.
ニューウェルシティ湯河原, 静岡.
2017年6月5日.
岩波翔也、山本玲、岩見真吾、波江野洋.
骨髄球バイパスを含む造血システムの数理モデル.
第３回数理生物学交流発表会.
静岡大学浜松キャンパス, 静岡.
2017年2月19日.
岩波翔也、山本玲、岩見真吾、波江野洋.
骨髄球バイパスを含む造血システムの数理モデル.
第１回理論免疫学ワークショップ.
JMSアステールプラザ, 広島.
2017年1月19日.
岩波翔也、山本玲、岩見真吾、波江野洋.
骨髄球バイパスを含む造血システムの数理モデル.
2016年度応用数学合同研究集会.
龍谷大学, 滋賀.
2016年12月15日.
岩波翔也、山本玲、岩見真吾、波江野洋.
骨髄球バイパスを含む造血システムの数理モデル.
RIMS研究集会 第13回「生物数学の理論とその応用」-連続および離散モデルのモデリングと解析-.
京都大学数理解析研究所, 京都.
2016年11月16日.
Iwanami S., Yamamoto R., Iwami S. and Haeno H..
Mathematical model of hematopoietic system with myeloid bypass.
Innovative Mathematical Modeling for the Analysis of Infectious Disease Data (IMAID2016).
Kobe University, Kobe, Japan.
2016年10月12日.
Iwanami S., Yamamoto R., Iwami S. and Haeno H..
Mathematical model of hematopoietic system with myeloid-restricted progenitors with long-term repopulating activity.
The 2016 (16th) annual meeting of The Japanese Society for Mathematical Biology.
Kyushu University, Fukuoka, Japan.
2016年9月9日.
研究費
公益財団法人豊田理化学研究所
2025年度豊田理研スカラー,
数理科学手法による加齢特異的な血球産生の理解,
代表,
2025年04月
- 2026年03月,
1,000,000円.
公益財団法人上原記念生命科学財団
2024年度研究奨励金,
数理的手法によるクローン性造血と造血器腫瘍の理解,
代表,
2025年02月
- 2026年04月,
2,000,000円.
公益財団法人持田記念医学薬学振興財団
2024年度研究助成,
ウイルス感染動態の定量化に基づく抗ウイルス薬評価手法の開発,
代表,
2024年12月
- 2025年12月,
3,000,000円.
公益財団法人大和証券財団
2024年度（第51回）調査研究助成,
造血器腫瘍とゲノム異常を関連づける数理解析手法の開発,
代表,
2024年10月
- 2025年09月,
1,000,000円.
科学技術振興機構
さくらサイエンスプログラム・さくら招へいプログラム,
異分野融合生物学研究,
実施主担当者,
2024年09月
- 2024年09月,
1,648,668円.
日本医療研究開発機構
次世代がん医療加速化研究事業,
染色体外DNAの分配ダイナミクスに影響を与える分子の同定,
分担（代表者：丸山玲緒）,
2024年09月
- 2027年03月,
9,000,000円.
日本医療研究開発機構
新興・再興感染症に対する革新的医薬品等開発推進研究事業,
エムポックスウイルス増殖機構の解明と治療薬開発に関する研究,
分担（代表者：日紫喜隆行）,
2024年05月
- 2025年03月,
1,000,000円.
日本医療研究開発機構
新興・再興感染症に対する革新的医薬品等開発推進研究事業,
侵襲性真菌感染症の迅速診断法と新規治療法の研究開発,
分担（代表者：宮崎泰可）,
2024年04月
- 2027年03月,
9,000,000円.
日本医療研究開発機構
新興・再興感染症に対する革新的医薬品等開発推進研究事業,
ドラッグリポジショニングによるエムポックス治療薬開発,
分担（代表者：日紫喜隆行）,
2023年10月
- 2024年03月,
1,000,000円.
日本医療研究開発機構
新興・再興感染症に対する革新的医薬品等開発推進研究事業,
糸状菌真菌症に対する疫学調査及び革新的診断法と治療法の研究開発,
分担（代表者：宮崎泰可）,
2023年07月
- 2024年03月,
2,500,000円.
日本医療研究開発機構
新興・再興感染症に対する革新的医薬品等開発推進研究事業,
新規抗サル痘ウイルス化合物の最適化とドラッグリポジショニングによる治療法の開発,
分担（代表者：日紫喜隆行）,
2022年10月
- 2023年03月,
3,000,000円.
日本学術振興会
科学研究費助成事業（若手研究）,
細胞群動態の変容を捉える多階層データ解析理論の構築,
代表,
2022年04月
- 2024年03月,
3,600,000円.
科学技術振興機構
戦略的創造研究推進事業（さきがけ）「パンデミックに対してレジリエントな社会・技術基盤の構築」領域,
数理科学が推進するパンデミックナレッジ基盤の構築,
代表,
2021年10月
- 2025年03月,
30,000,000円.
日本学術振興会
特別研究員奨励費,
組織維持を担う細胞群個体群動態の理解と定量的データ解析,
代表,
2019年04月
- 2021年03月,
1,700,000円.
Update: Jun 22, 2022